How Common Is Kidney Cancer? Prevalence, Risk, and Outlook

Explore the prevalence, risk factors, and survival trends of kidney cancer in the U.S. and worldwide.

By Sneha Tete, Integrated MA, Certified Relationship Coach
Created on

Kidney cancer is a major health concern worldwide, ranking among the most frequently diagnosed cancers. With rising global incidence and distinctive risk profiles, understanding the latest facts about prevalence, risk, and survival can help individuals and caregivers recognize and manage the risk effectively. This guide comprehensively covers how common kidney cancer is, who is most susceptible, the types and aggressiveness of this disease, as well as prevention and survival factors.

Kidney Cancer at a Glance

  • One of the 10 most common cancers in the U.S.
  • Among the top 14 most common cancers globally
  • Affects over 600,000 people in the United States
  • Higher rates in men than women
  • Incidence increases with age, often diagnosed in older adults

How Common Is Kidney Cancer?

Kidney cancer is notably prevalent in the United States and worldwide:

  • In 2023, the American Cancer Society forecasted 81,800 new cases of kidney cancer in the U.S.
  • As of 2022, an estimated 676,631 people in the U.S. are living with kidney and renal pelvis cancer.
  • Globally, it is the 14th most common cancer, but the U.S. ranks as the 7th highest nation for kidney cancer incidence.

The risk profile is not uniform—some individuals face much higher odds than others due to gender, race, genetics, and environmental factors. The most prevalent type is renal cell carcinoma (RCC), comprising about 85-90% of all kidney cancers.

Odds of Developing Kidney Cancer

  • Men: Lifetime risk is about 1 in 46 (2.2%)
  • Women: Lifetime risk is around 1 in 80 (1.2%)

Kidney cancer is less common than cancers of the skin, breast, prostate, or lung, but it still impacts a substantial number of individuals annually.

Kidney Cancer Statistics: U.S. and Global Perspective

Kidney Cancer: Rates and Prevalence
Region/CountryNew Cases per YearIncidence Rate* (ASR)Population Affected (2022)
United States~81,80012.8 per 100,000676,631 currently living with diagnosis
Belarus2,27614.1 per 100,000Highest rate worldwide
Uruguay77714.0 per 100,000
Global~403,0004.4 per 100,000 (avg.)Millions worldwide

*ASR: Age-standardized rate per 100,000 persons per year

By Gender

  • Men are approximately 1.7 times more likely to be diagnosed than women.

By Race and Ethnicity (U.S. Data)

Incidence Rate per 100,000 (Age-Adjusted)
PopulationMalesFemales
All Races23.812.0
Hispanic24.614.4
Non-Hispanic American Indian/Alaska Native39.220.2
Non-Hispanic Asian/Pacific Islander12.15.7
Non-Hispanic Black25.913.2
Non-Hispanic White24.611.9

Rates are significantly higher among non-Hispanic American Indian/Alaska Native populations.

Types of Kidney Cancer

There are several types of kidney cancer. The most common is:

  • Renal cell carcinoma (RCC): About 85–90% of all kidney cancers
  • Urothelial carcinoma: Originates in the urinary tract lining
  • Wilms tumor: Primarily affects children
  • Other rare types: Collecting duct tumors, renal sarcomas, and more

Each type has unique characteristics and may affect treatment options and prognosis.

Who Gets Kidney Cancer? Risk Factors

While anyone may develop kidney cancer, certain risk factors heighten the likelihood. Major risk factors include:

  • Age: Diagnosis most common after age 45, with the majority in those aged 65–74
  • Gender: Men are more frequently affected than women
  • Race/Ethnicity: Non-Hispanic American Indian/Alaska Native people have higher rates
  • Family history: Having first-degree relatives with kidney cancer increases risk
  • Smoking: Raises risk significantly
  • Obesity: Linked to increased incidence
  • High blood pressure (hypertension)
  • Chronic kidney disease and long-term dialysis
  • Exposure to certain chemicals (e.g., trichloroethylene)
  • Some inherited syndromes (e.g., von Hippel-Lindau disease)

Table: Distribution by Age Group (U.S.)

New Cases by Age Group
Age RangePercent of New Cases
<20 years0.9%
20–341.7%
35–445.9%
45–5413.8%
55–6425.9%
65–7430.0%
75–8416.8%
85+5.1%

The median age at diagnosis is 65. Kidney cancer is rare in children and young adults.

Aggressiveness and Outlook: Is Kidney Cancer Curable?

The outlook for kidney cancer varies greatly by stage at diagnosis, type, and the person’s overall health. Early-stage kidney cancers are often highly treatable, while advanced cancers can be more difficult to cure. Key points:

  • Localized tumors (found only in the kidney) have some of the best survival rates
  • Metastatic or advanced kidney cancer (spread to other organs) is more challenging to treat but some respond well to targeted therapies or immunotherapy
  • Surgical removal of the tumor or kidney is the main treatment for many early-stage cases

Many people with kidney cancer, especially if diagnosed early, can expect favorable long-term outcomes.

Kidney Cancer Prevention: Reducing Your Risk

While not all cases can be prevented, certain lifestyle choices and health management steps can help lower your risk:

  • Quit smoking if you currently smoke
  • Maintain a healthy weight through diet and exercise
  • Manage high blood pressure with regular checkups and medication if needed
  • Avoid exposure to workplace toxins (especially trichloroethylene)
  • Monitor and manage chronic kidney disease carefully
  • Be aware of family medical history and discuss genetic counseling if relevant

While these steps cannot eliminate risk entirely, they can significantly reduce the odds of developing kidney cancer or support better health outcomes after diagnosis.

Frequently Asked Questions (FAQs)

Q: How common is kidney cancer compared to other cancers?

A: Kidney cancer is among the top 10 most common cancers in the United States and the 14th most common worldwide. It is less prevalent than some cancers, like those of the lung, breast, or prostate, but is a significant health concern globally.

Q: Who is at higher risk for kidney cancer?

A: People over 45, men, non-Hispanic American Indian/Alaska Native individuals, smokers, those with obesity, and those with certain genetic conditions or a family history of kidney cancer have higher risk.

Q: What is renal cell carcinoma, and why is it important?

A: Renal cell carcinoma (RCC) is the most common type of kidney cancer, comprising about 85–90% of adult cases. Understanding RCC is vital as it dictates most diagnosis, treatment, and research focus.

Q: Can kidney cancer be cured?

A: Many early-stage kidney cancers can be effectively treated and even cured, typically with surgery or targeted therapy. Advanced cancers are more challenging but there are increasing treatment options.

Q: Are there ways to actively reduce kidney cancer risk?

A: Yes. Not smoking, maintaining a healthy weight, controlling blood pressure, avoiding hazardous chemicals, and addressing chronic kidney disease all help to reduce kidney cancer risk.

Key Takeaways

  • Prevalence: Kidney cancer is highly common, especially in the U.S., affecting over half a million people.
  • Demographics: Men, older adults, and certain racial groups have greater risk.
  • Early Diagnosis Matters: Prompt detection and treatment significantly improve chances of cure and long-term survival.
  • Lifestyle Changes: Healthy lifestyle choices and management of medical risk factors can lower odds of developing this cancer.

If you or someone you know is at increased risk, consulting a healthcare professional and regular screenings may help with early detection and improved outcomes.

Sneha Tete
Sneha TeteBeauty & Lifestyle Writer
Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to thebridalbox, crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete